Deep-learning technology could help scientists to develop personalized immunotherapies and vaccines

Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response.

Related Keywords

California ,United States ,San Diego ,Benjamin Alexander Albert ,Johns Hopkins ,Valsamo Elsa Anagnostou ,Rachel Karchin ,Danielle Ellis ,Dipika Singh ,Yunxiao Yang ,Kellie Smith ,Astra Zeneca ,Xiaoshan Shao ,Bloomberg Kimmel Institute For Cancer Immunotherapy ,University Of California ,Genentech ,National Institutes Of Health ,Bristol Myers Squibb ,Kimmel Cancer Center ,Institute For Computational Medicine ,Johns Hopkins Institute For Computational Medicine ,Johns Hopkins Kimmel Cancer Center ,Thoracic Malignancies Integrated Translational Science Center ,Johns Hopkins University ,Nature Machine Intelligence ,Johns Hopkins Biomedical Engineering ,Johns Hopkins Institute ,Computational Medicine ,Kimmel Institute ,Johns Hopkins Molecular Tumor Board ,Precision Oncology Analytics ,Kimmel Cancer ,National Institutes ,Personal Genome Diagnostics ,Delfi Diagnostics ,Cancer ,Ntigen ,Ancer Immunotherapy ,Fell ,Iagnostics ,Enome ,Immune Response ,Immune System ,Immunotherapy ,Medicine ,Utation ,Ncology ,Mh ,Protein ,Eceptor ,Research ,T Cell ,Technology ,Humor ,